Skip to content

SION SION Operating Lease Right-of-Use Assets in Other Assets

Operating Lease Right-of-Use Assets in Other Assets at other companies

Vertex Pharmaceuticals logo
Vertex PharmaceuticalsVRTX
Septerna, Inc. logo
Septerna, Inc.SEPN
Denali Therapeutics Inc. logo
Denali Therapeutics Inc.DNLI
Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX

Other financials

Income statement

See full
Operating income-$29.6M-50.6%
Net income-$26.8M-62.5%
EPS (diluted)-$0.60+3.2%

Balance sheet

See full
Cash & equivalents$64.3M-23.2%
Total debt$8.4M-11.8%
Total equity$288.2M-18.1%
Total assets$305.0M-17.5%

Cash flow

See full
Operating cash flow-$21.8M-34.1%
CapEx--100%
Free cash flow-$21.8M-33.4%

Valuation

See full
Market cap$1.86B

Returns & leverage

See full
Return on equity-26.7%
Debt / equity0.0×
Current ratio22.6×-6.1×

Where this comes from

Reported directly by SION in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.

The official record: SION’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about SION's operating lease right-of-use assets in other assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is SION's operating lease right-of-use assets in other assets?
SION (SION) reported operating lease right-of-use assets in other assets of $6.68M in Q1 2026.
How has SION's operating lease right-of-use assets in other assets changed year-over-year?
SION's operating lease right-of-use assets in other assets decreased by 12.3% year-over-year, from $7.62M to $6.68M.